Sun, Jul 13, 2014, 10:20 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jesse.livermore jesse.livermore Oct 11, 2012 7:45 AM Flag

    Anatomy of a Biotech Sale....

    Akanz and Epi...

    Thnx for the support...

    Gary, When I mention six months off, I'm considering a few months sales to get a grip on how the medical community is warming up to Vascepa, not the launch date,which should occur in Q1 2013.

    Right now I do not see a sale in the next few months being a good idea for either the buyer or the seller. Although this company is a biotech, it more closely resembles a retailer and its value is going to be tied to revenue generation. Once the drug hits the market both parties will have a better idea of the company's value...which right now would just be a guess for either side.

    Epi..Re the Quiet period....Have no information why this anomaly is taking place...Could be they are in discussion with a partner for marketing and sales with an eye to the future development of a combined statin-EPA drug....Doubt it's NCE related, or a buyout...

    ": ) JL

    Sentiment: Strong Buy

 
AMRN
1.59-0.02(-1.24%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
DHT Holdings, Inc.
NYSEFri, Jul 11, 2014 4:03 PM EDT